Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the DNAbilize, a platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone...
7 insider purchases on record · latest filing 2015-07-15.
Insiders have also filed 1 sale transaction at BPTH.